<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="31%"></col>
<col width="31%"></col>
<col width="30%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Concomitant Drug Name or Drug Class </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Clinical Rationale and Magnitude of Drug Interaction </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Clinical Recommendation </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>CYP3A4 inhibitors, e.g.,ketoconazole </paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Guanfacine is primarily metabolized by CYP3A4 and its plasma concentrations can be significantly affected resulting in a 200% increase in exposure </paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Consider dose reduction <content stylecode="italics">[see Dosage and Administration (</content>
<content stylecode="italics">
<linkhtml href="#i4i_section_id_a11fd741-742c-43fa-82dd-2eea9b1f814d">2.7</linkhtml>
</content>
<content stylecode="italics">)] </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>CYP3A4 inducers, e.g., rifampin </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Guanfacine is primarily metabolized by CYP3A4 and its plasma concentrations can be significantly affected resulting in a 60% decrease in exposure </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Consider dose increase <content stylecode="italics">[see Dosage and Administration (</content>
<content stylecode="italics">
<linkhtml href="#i4i_section_id_a11fd741-742c-43fa-82dd-2eea9b1f814d">2.7</linkhtml>
</content>
<content stylecode="italics">)] </content>
</paragraph>
</td>
</tr>
</tbody>
</table>